Medtech

2 stories · following the connections

Investing

S&P Raises EssilorLuxottica’s Long-Term Rating to A+ With Stable Outlook

By Celia RowanOct 23, 2026, 8:33 PM UTC

Business

EY Reports $650 Billion in Medtech Revenue as Growth Favors Leaders

By Helena WardOct 19, 2026, 7:31 PM UTC